Treatable Leigh-like encephalopathy presenting in adolescence
Authors:
Open Access
- 7 October 2013
- journal article
- case report
- Published by BMJ in BMJ Case Reports
- Vol. 2013, 200838
Abstract
Wernicke's encephalopathy is a triad of ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1(thiamine) deficiency. A rare genetic defect of thiamine transporter-2 may lead to similar clinical features, biotin-thiamine responsive basal ganglia disease (BTBGD). A 15-year-old girl developed rapid onset ptosis and ophthalmoplegia evolving into a subacute encephalopathy. Neuroimaging demonstrated symmetrical basal ganglia and mid-brain lesions reminiscent of Leigh's subacute necrotising encephalomyelopathy. Oral biotin and thiamine were started, and symptoms improved dramatically the next day. The therapeutic response suggestedSLC19A3, encoding thiamine transporter-2, as a strong candidate gene and Sanger sequencing revealed a novel homozygous c.517A>G;p.Asn173Asp mutation, which segregated with disease within the family. BTBGD is a potentially treatable neurological disorder and should be considered in the differential diagnosis of Leigh syndrome and Wernicke's encephalopathy. Since delayed treatment results in permanent neurological dysfunction or death, prompt diagnosis and early initiation of biotin and thiamine therapy are essential.Keywords
This publication has 17 references indexed in Scilit:
- Genome-Wide Association Analysis Identifies a Mutation in the Thiamine Transporter 2 (SLC19A3) Gene Associated with Alaskan Husky EncephalopathyPLOS ONE, 2013
- Exome sequencing reveals a novel Moroccan founder mutation inSLC19A3as a new cause of early-childhood fatal Leigh syndromeBrain, 2013
- Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new casesOrphanet Journal of Rare Diseases, 2013
- A wide spectrum of clinical and brain MRI findings in patients with SLC19A3mutationsBMC Medical Genetics, 2010
- Mutations in a Thiamine-Transporter Gene and Wernicke's-like EncephalopathyNew England Journal of Medicine, 2009
- Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2American Journal of Physiology-Cell Physiology, 2006
- Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafnessNature Genetics, 1999
- Biotin-responsive basal ganglia disease: a novel entityBrain, 1998
- Leigh syndrome: Clinical features and biochemical and DNA abnormalitiesAnnals of Neurology, 1996
- Subacute Necrotizing Encephalomyelopathy (Leigh's Disease): a Consideration of Clinical Features and EtiologyDevelopmental Medicine & Child Neurology, 1972